• en
  • it
  • de
  • Teriflunomide – API and Licensing Agreements for Tablets available

    PharmaZell Group is pleased to announce that the US Food and Drug Administration has granted approval of Breckenridge Pharmaceutical, Inc. Abbreviated New Drug Application for Teriflunomide 7mg & 14mg Tablets (generic for Aubagio®) on September 24, 2021. This product was developed by PharmaZell in collaboration with Breckenridge. The received FDA approval will allow Breckenridge, based

    Update on 5-ASA New Project in Vizag (India)

    New expansion of fully automated and dedicated Production facility for Mesalamine has picked up its momentum at Visakhapatnam site. It is targeted to start the production in October-2021. Impact of COVID-19 lead to few disturbances for 2-3 weeks,  however there are adeuqate buffer time in plan to mitigate potential delays. Majority of the equipment are

    Private Equity owner Bridgepoint visits PharmaZell Group’s company Farmabios

    In October 2020 our new investor Bridgepoint visited the Farmabios site in Gropello-Cairolli (Italy). Besides holding its regular board meeting, the attendees went on an extensive plant tour. They were impressed by its capabilities, the in-depth know-how of its employees and the rapid progress of the new steroid building construction. The latter is going to

    search for what
    Generic filters
    Exact matches only